30th KIHE 2025

Date: 21-23 May 2025

Venue：Atakent International Convention Center

Organizer：ICA GROUPS, Iteca Exhibitions

Frequency:  Annual 

Introduction: 

Kazakhstan International Healthcare Exhibition (KIHE) is the largest demonstration platform in Central Asia for achievements in the field of scientific-practical medicine and pharmaceuticals, which annually brings together doctors of various specialties, pharmacists, government and business representatives from different countries. Every year, manufacturers and suppliers of medical equipment, instruments, clinic and laboratory consumables, medical products for various purposes, equipment for production, packaging and labeling of pharmaceutical preparations, etc. participate in the exhibition.
Alongside the exhibition, international forums, conferences, round tables and master classes are held concurrently, attended by representatives of state authorities, entrepreneurs, heads of medical institutions and pharmaceutical companies. 45% of the stands at the 2024 exhibition belonged to Kazakhstani companies, which demonstrates the very bright and impressive development of the healthcare sector in Kazakhstan.
KIHE is also officially supported by the Ministry of Health of the Republic of Kazakhstan, the Department of Public Health of the State Agency of the City of Almaty, the International Association of Pharmaceutical Manufacturers of the Republic of Kazakhstan, the Eurasian Medical Association, and the Association for the Support and Development of Pharmaceutical Activities of the Republic of Kazakhstan. This is also a strong indication that Kazakhstan is becoming a center of attraction for the world's leading manufacturers and suppliers of medical equipment and innovative solutions, and as a result, also 55% of the international companies have actively registered for the exhibition as well.
Facts and data: 

Visitors: 4,543; Exhibitors: 329 from 19 countries; Exhibition Area: 5,165 square meters, including 3 conference halls, 29 business areas; and 95 speakers from 6 countries.

Visitor Positions: 39% Manager/Specialist, 33% Company Head/Owner, 9% Individual Entrepreneur, 8% Government Agency Representative, 6% Department Head, 5% Chief Medical Officer/Deputy Chief Medical Officer

Visitors came from 36 countries, of which 49% were first-time visitors: 86% Kazakhstan, 9% from CIS countries, 5% from abroad.

Exhibitors also had a very high opinion of KIHE 2024: 96% considered KIHE 2024 to be very positively important for their business development; 97% would recommend the show to their partners; 95% achieved or mostly achieved their expectations; 95% were very satisfied with the show; 84% have decided or plan to continue to participate in KIHE 2025. 

Why Exhibits: 

1. 3 days of professional communication with potential customers and partners in a comfortable business atmosphere;

2. Additional tools to promote the product and effective ways to increase the company's visibility;

3. The possibility of expanding the customer base;

4. Highly informative and demonstrative. Receive and share information on market trends in a short period of time.

Products: 

Raw Materials & Ingredients for Pharmaceutical Industry, Intermediates, Pharmaceutical Equipment, Pharmaceutical Packaging, Laboratory Equipment & Reagents, Control Instruments & Devices, Clinical Research, Clean Room Technology, Pharmaceutical Engineering, Personal Protective Equipment, Equipment & Consumer Products for Quality Assurance, Auxiliary Software for the Pharmaceutical Industry, O

phthalmic Optics, Diagnostic Devices, Prosthetic Devices & Inventions, Operating Room Instruments, First Aid & Rescue Devices, Biologicals, Dental, Medical Manufacturing & Control Equipment, Laboratory Equipment & Instruments, Medical Products, New Technologies & Equipment, Equipment for Hospitals & Nursing Homes, Emergency Care, Fitness Equipment, Weight Loss Products, Nutritional Products, Medical Apparel, Personal Hygiene Products, Incontinence Products, Modern Information Technology for Health Protection Services, etc.

Market Profiles: 

In Kazakhstan, the government owns 80% of the medical companies. Because of this, the government plays a very important role in medical issues. There are also many joint ventures between the government and private healthcare organizations, for example, 70% of the dental clinics are privately owned, but usually public health services are carried out under the control of state and municipal authorities. During the past few years, the government has made a lot of management measures on public health reform and development. Public health reform and development programs have been adopted, the catalog of free medical assistance has been constantly introduced, and this year has been called the Year of Health. Currently, the Government of the Republic of Kazakhstan has intensified the treatment of tuberculosis, diabetes, AIDS, oncological diseases and other diseases caused by iodine deficiency, and the program has begun to be implemented in these directions.

Kazakhstan's pharmaceutical industry is extremely underdeveloped, and more than 70% of medicines need to be imported; local enterprises can only produce part of the conventional medicines, and all patented medicines need to be imported, and even some infusion products need to be imported. Foreign medicines registered in Kazakhstan come from 57 countries, with origins in 99 countries. Locally manufactured medicines are mainly herbal preparations. The annual per capita use of medicines in Kazakhstan is $18.82, while in Eastern European countries it is $80-120 and in developed countries $124-345.

According to the Ministry of Public Health of the Republic of Kazakhstan, the import of medical equipment has increased by 95%, while 97% of medical preparations circulate on the market through the private sector.

Nowadays, more than 100 companies representing countries are registered in Kazakhstan. The largest suppliers of medical preparations are from Russia, Germany, France and the USA.

The government has also implemented policies to encourage the development of pharmaceuticals: Kazakhstan's Health Strategy Development Plan 2020 lists the pharmaceutical industry as a key industry for development; in 2016, it was determined that the government is expected to invest 33 million U.S. dollars in the development of the pharmaceutical industry in the next 20 years, and the proportion of domestically produced medicines will be increased to 50% by 2018; the GMP standards implemented by the government have further standardized and facilitated the development of the pharmaceutical industry in the country. According to the data analysis, the current medical equipment market demand for the highest equipment as follows: electronic medical equipment, diagnostic equipment, endoscopy, medical laser equipment, dental equipment and so on.